EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

In vitro, cellular and in vivo studies of amyloid oligomers structure and toxicity: Challenges and advances

Magdalena I Ivanova iD, Carmelo La Rosa, Ayyalusamy Ramamoorthy

Protein Science · 2026-04 · 35 (4)

DOI: 10.1002/pro.70525 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Protein Science, online erschienen am 12.03.2026. Verfasst von Magdalena I Ivanova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biophysics Program, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Amyloid, Amyloidogenic Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 299 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Science Foundation, State of Florida.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oligomeric assemblies of amyloidogenic proteins, such as Aβ, tau, α‐synuclein, amylin, transthyretin, and TDP‐43, are increasingly recognized as key drivers of cellular dysfunction across a range of neurodegenerative and systemic disorders. However, their molecular properties remain poorly understood due to their low abundance, structural heterogeneity, and transient nature. This review outlines current methods for studying amyloid oligomers, including biophysical (NMR, cryo‐EM, HS‐AFM, mass spectrometry), computational (molecular dynamics simulations), and biological (cellular assays, organoids, and animal models) approaches. This review also covers emerging methods for detecting misfolded proteins within complex biological environments and live‐cell systems. Furthermore, we discuss recent advances that specifically address the challenges of studying oligomers, which are yielding crucial data on how these pathogenic species impair cellular homeostasis. Given the heterogeneity and transient nature of the oligomers, it is essential to utilize findings across diverse experimental platforms that yield complementary data and apply methods that also ensure reproducibility and mechanistic clarity with the goal of translating these findings into effective therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmyloidAmyloidogenic ProteinsHumansAnimalsProtein Folding

Stichwörter der Autor:innen

amyloidbiophysical methodscellular modelsdiseaseoligomerspolymorphismprotein aggregationprotein misfoldingstructure

Substanzen

AmyloidAmyloidogenic Proteins

Autor:innen und Institutionen

  • Biophysics Program, University of Michigan, Ann Arbor, Michigan, USA.
  • Michigan Neuroscience Institute, University of Michigan, Ann Arbor, Michigan, USA.
  • Dipartimento di Scienze Chimiche, Università degli Studi di Catania, Catania, Italy.
  • Department of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Florida State University, Tallahassee, Florida, USA.
  • National High Magnetic Field Laboratory, Tallahassee, Florida, USA.
  • Institute Molecular Biophysics, Florida State University, Tallahassee, Florida, USA.

ORCID-Profile: Magdalena I Ivanova

Förderung

  • NIH HHS
  • National Science Foundation
  • State of Florida
  • National Institutes of Health

Zitieren

APA

Ivanova, M. I., La Rosa, C., & Ramamoorthy, A. (2026). In vitro, cellular and in vivo studies of amyloid oligomers structure and toxicity: Challenges and advances. Protein Science, 35(4). https://doi.org/10.1002/pro.70525

Vancouver

Ivanova MI, La Rosa C, Ramamoorthy A. In vitro, cellular and in vivo studies of amyloid oligomers structure and toxicity: Challenges and advances. Protein Science. 2026;35(4). doi:10.1002/pro.70525

BibTeX
@article{Ivanova2026,
  author = {Ivanova, Magdalena I and La Rosa, Carmelo and Ramamoorthy, Ayyalusamy},
  title = {In vitro, cellular and in vivo studies of amyloid oligomers structure and toxicity: Challenges and advances},
  journal = {Protein Science},
  year = {2026},
  volume = {35},
  number = {4},
  doi = {10.1002/pro.70525}
}
Kostenlos starten →